The U.S. provides nearly half of the aid for global health, including childhood vaccination, H.I.V. treatment and disease surveillance.
Tag: Gavi, the Vaccine Alliance
Biden Will Take Cancer ‘Moonshot’ Global at Summit in Delaware
The president will join the leaders of Australia, India and Japan to announce a new initiative for reducing cervical cancer in the Indo-Pacific, a region with especially high rates of the disease.
W.H.O. Authorizes Mpox Vaccine, Clearing Way for Use in Africa
The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.
Malaria Vaccine Rollout to Africa Is a Cautionary Tale
After years of delay, millions of malaria vaccines are being supplied to children in Africa. Tens of thousands died waiting.
Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spread
One company is going to great lengths to build it up, but it will be years before it returns to the minimum level.
Unvaccinated and Vulnerable: Children Drive Surge in Deadly Outbreaks
About 60 million “zero-dose children” have not received any vaccines and have aged out of routine immunization programs. Protecting them will require a costly vaccination blitz.
Shot to Protect Against Polio and Five Other Diseases Is Approved by Gavi
The international vaccine aid group agreed to provide developing countries with a new shot to prevent a global resurgence of the paralyzing virus.
An African Country Faces Challenges to Protect Girls From HPV
Almost all cervical cancer deaths now occur in developing countries. Tanzania is trying to inoculate girls against the virus that causes the disease — nearly 20 years after rich countries began offering the shot.
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
Key Partner in Covax Will End Support for Middle-Income Nations
Many of the poorest countries will continue to get free Covid shots, but global demand for them has plummeted, driving a shift away from the goal of broad coverage.